Spruce Biosciences Inc. (SPRB)
NASDAQ NASDAQ Primary 
Spruce Biosciences, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Spruce Biosciences (SPRB)
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
Investors In Spruce Biosciences Inc Are Urged To Join The Schall Law Firm In An Investigation For Possible Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Lost Money on Spruce Biosciences, Inc. (SPRB)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
The Schall Law Firm Invites Shareholders To Participate In An Inquiry Into Spruce Biosciences Inc For Potential Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Lost Money on Spruce Biosciences, Inc. (SPRB)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
Investors Who Lost Money on Spruce Biosciences, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - SPRB
NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
Shareholders Are Invited To Contact The Schall Law Firm About Spruce Biosciences Inc's Potential Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Spruce Biosciences, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - SPRB
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
Levi & Korsinsky Reminds Shareholders of an Investigation into Spruce Biosciences, Inc. (SPRB) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
Levi & Korsinsky Reminds Spruce Biosciences Investors of the Ongoing Investigation into Potential Violations of Securities Laws - SPRB
NEW YORK, NY / ACCESSWIRE / August 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
Lost Money on Spruce Biosciences, Inc.(SPRB)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.
Investors With Losses In Spruce Biosciences Inc Invited To Contact Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
